To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06279728
Title Medical Access Program for Datopotamab Deruxtecan in NSCLC Patients
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Daiichi Sankyo
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology Group AVAILABLE Springdale Arkansas 72762 United States Details
Queen's Medical Center AVAILABLE Honolulu Hawaii 96813 United States Details
Karmanos Cancer Institute (Barbara Ann Karmanos Cancer Hospital) AVAILABLE Detroit Michigan 48201 United States Details
Karmanos Cancer Institute AVAILABLE Detroit Michigan 48201 United States Details
Henry Ford Health AVAILABLE Detroit Michigan 48202 United States Details
Central Care Cancer Center AVAILABLE Bolivar Missouri 65613 United States Details
Overlook Medical Center Medical Diagnostic Associates Atlantic Medical Group AVAILABLE Summit New Jersey 07901 United States Details
New York Cancer & Blood Specialists AVAILABLE New York New York 10028 United States Details
University of Texas Southwestern Medical AVAILABLE Dallas Texas 75390 United States Details
Houston Methodist Hospital Cancer Center AVAILABLE Houston Texas 77030 United States Details
Northwest Medical Specialties, PLLC AVAILABLE Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field